Metformin has shown beneficial effects in the management of T2D as a widely used first-line treatment for diabetes mellitus, so we next investigated whether IHMT-MST1-39 has synergistic anti-diabetic effect in combination with metformin in vivo. The gene discussed is MST1; the disease is type 2 diabetes mellitus.